Office-based testing for fecal occult blood: Do only in case of emergency

Annals of Internal Medicine

Volumn 142, Issue 2, 2005, Pages 146-148

  Sox, Harold C ^a  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTRAST RADIOGRAPHY; EMERGENCY; HUMAN; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY;

EID: 11844285741     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-2-200501180-00014     Document Type: Review

References (10)

1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer .cancer.gov). SEER*Stat Database: Mortality-All COD, Public-Use with State, Total U.S. (1969-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004. Underlying mortality data provided by National Center for Health Statistics (www.cdc.gov/nchs).
2. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-7. [PMID: 1736103]
3. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. [PMID: 10070942]
4. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer .cancer.gov). SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission.
5. Screening for colorectal cancer recommendation and rationale. U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:129-31. [PMID: 12118971]
6. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004;99:1544-50. [PMID: 15307875]
7. Sox CH, Dietrich AJ, Tosteson TD, Winchell CW, Labaree CE. Periodic health examinations and the provision of cancer prevention services. Arch Fam Med. 1997;6:223-30. [PMID: 9161346]
8. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86-94.
9. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142: 81-5.
10. American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology. 2000;118:197-201. [PMID: 10611169]